Real-time molecular probe-directed intraprocedural biopsies

JOINT EVENT: 4^th International Conference and Exhibition on Medical Physics and Biophysics & 2^nd International Conference on Nuclear Medicine & Radiation Therapy

July 27-28, 2017 Rome, Italy

Carina Mari Aparici

University of California San Francisco, USA

Scientific Tracks Abstracts: J Nucl Med Radiat Ther

Abstract :

The clinical management of lesions suspicious for malignancy relies not only on diagnosis of benign versus malignant potential but also tumor grading, immunohistochemical and genetic information. Pathological analysis remains the gold standard for definite diagnosis. Hence, a carefully performed biopsy with low risk of complication is crucial. Compared to open biopsy, image-guided biopsies are minimally invasive and confer several advantages including low morbidity, low complication rate and cost savings. FDG-PET/CT has shown higher diagnostic accuracy than conventional imaging CT in characterizing tumor in initial staging, treatment response evaluation and follow-up. PET/CT guided biopsies may allow early histologic diagnosis and staging before morphologic changes are evident. PET/CT biopsy can therefore rule out/in malignancy in early stage of disease and re-stage different types of cancer. Non-real-time PET/CT biopsies have used the image co-registration of a prior PET with a intraprocedural CT. However, this method is inaccurate in time and space, takes long time and requires special software. The aim of this study is to report the initial experience of utilizing the real-time intraprocedural PET/CT guided biopsies, including feasibility and technical requirements.

Biography :

Carina Mari Aparici is an Associate Professor in Residence at UCSF. She is a Nuclear Physician with residencies in both Europe (Barcelona) and US (Stanford), and with Molecular imaging fellowships from Stanford University. She is a Physician-Scientist in the development of Molecular Imaging. She has about 20 years of clinical and research experience in the field, and 10 years of a leadership position as Chief Nuclear Medicine at the San Francisco VAMC as part of her faculty position at UCSF. She has published 100 papers in reputed journals and has been serving as an Editorial Board Member of repute.

Email: Carina.Mari@ucsf.edu